Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -4.25% | -7.94% | -11.42% | -12.64% | -9.38% |
| Total Other Revenue | 36.71% | 17.53% | 33.76% | 33.76% | 8.70% |
| Total Revenue | -3.69% | -7.51% | -10.82% | -12.05% | -9.17% |
| Cost of Revenue | 12.88% | 6.39% | -2.09% | -5.49% | -5.35% |
| Gross Profit | -31.55% | -29.85% | -25.00% | -22.49% | -14.96% |
| SG&A Expenses | 3.19% | 3.36% | 10.79% | 9.42% | -0.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -111.72% | 72.22% | -75.22% | -97.08% | -58.93% |
| Total Operating Expenses | 10.80% | 5.39% | -0.63% | -3.73% | -4.94% |
| Operating Income | -61.63% | -54.83% | -46.43% | -40.04% | -22.92% |
| Income Before Tax | -36.48% | -73.56% | -80.19% | -73.83% | -57.32% |
| Income Tax Expenses | -30.60% | -41.31% | -39.14% | -37.16% | -36.94% |
| Earnings from Continuing Operations | -37.83% | -80.50% | -87.24% | -79.58% | -60.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 62.50% | 124.78% | 144.17% | 65.51% | 72.85% |
| Net Income | -36.10% | -73.83% | -80.49% | -80.43% | -58.94% |
| EBIT | -61.63% | -54.83% | -46.43% | -40.04% | -22.92% |
| EBITDA | -53.04% | -47.80% | -40.62% | -35.22% | -19.75% |
| EPS Basic | -36.12% | -73.51% | -80.66% | -80.63% | -58.84% |
| Normalized Basic EPS | -42.11% | -39.17% | -35.64% | -44.73% | -6.45% |
| EPS Diluted | -36.04% | -73.49% | -80.65% | -80.62% | -58.89% |
| Normalized Diluted EPS | -42.11% | -39.17% | -35.64% | -44.73% | -6.39% |
| Average Basic Shares Outstanding | -0.83% | -1.09% | -0.48% | -0.22% | -0.34% |
| Average Diluted Shares Outstanding | -0.83% | -1.09% | -0.48% | -0.22% | -0.44% |
| Dividend Per Share | -47.01% | -47.01% | -47.01% | -47.01% | 1.68% |
| Payout Ratio | -0.07% | 4.43% | 4.72% | 4.60% | 1.53% |